Efficacy of Pneumococcal Vaccine 13-Valent (PCV13) for Pneumonia Prevention
Keywords:
pneumonia, Pneumococcal vaccine 13-valent (PCV13), clinical studies, safety, efficacyAbstract
The purpose of this article was to study the Pneumococcal vaccine 13-valent (PCV13) for the prevention of pneumonia, providing a source of knowledge for those interested in PCV13. From 2023 to 2024, the authors rigorously reviewed research papers from both Thailand and international sources, including reputable organizations such as the World Health Organization, the Centers for Disease Control of the United States, the National Center for Biotechnology Information of the United States, and a vaccine textbook from the Bureau of General Communicable Diseases, Department of Disease Control, Thailand. A total of 34 articles were scrutinized to ensure the reliability of the information. The findings indicate that PCV13 is safe for preventing pneumonia, reduces the severity of the disease, and can lower the mortality rate without causing any serious side effects that could lead to death.
References
Centers for Disease Control and Prevention. Pneumonia. 2021. [cited May 27, 2023]. Available from: https://www.cdc.gov/dotw/pneumonia/index.html
National Heart, Lung, and Blood Institute. Pneumonia. 2022. [cited May 27, 2023]. Available from: https://www.nhlbi.nih.gov/health/pneumonia/prevention
Dion CF, Ashurst JV. Streptococcus pneumoniae. National Library of Medicine. 2023. [cited May 27, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470537/
Regunath H, Oba Y. Community-acquired pneumonia. National Library of Medicine. 2022. [cited May 27, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430749/
Centers for Disease Control and Prevention. Pneumococcal. 2023. [cited May 27, 2023]. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/index.html
World Health Organization. Pneumonia in children. 2022. [cited May 28, 2023]. Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia
Poovieng J, Sakboonyarat B, Nasomsong W. Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia, and hospital-acquired pneumonia in a Thai university hospital. Sci Rep 2023;12:9004. doi: 10.1038/s41598-022-12904-z.
Department of Disease Control Announcement. Prevention of diseases and health hazards during winter in Thailand, 2023. Department of Disease Control, Ministry of Public Health. 2023. [cited June 12, 2024]. Available from: https://ddc.moph.go.th/uploads/publish/1501520231123052757.pdf
Kittayakhom K, Rattanachotphanit T, Limwattananonta S. Costs of admission to Kumphawapi Hospital in patients with pneumonia. Thai J Pharm Pract 2021;13(1):189-201.
Jantarat P, Nijaranond L, Sepmongkonlerd S, Jitpiboon W, Sangthong R. Situation and healthcare cost among hospitalized patients aged 1 month to 5 years with pneumonia. Maharaj Nakhon Si Thammart Med J 2020;4(1):65-74.
Gamil A, Chokephaibulkit K, Phongsamart W, Techasaensiri C, Piralam B, Thamaree R. Pneumococcal disease in Thailand. Int J Infect Dis 2021;102:429-36. doi:10.1016/j.ijid.2020.10.0
Pongsamesa T, Janyasupap S. Current guidelines for the use of antibiotics in the treatment of community-acquired pneumonia. Thai J Pharm Sci 2005;2:17-28. doi:10.14456/tbps.2005.2.
Centers for Disease Control and Prevention. Pneumococcal disease in adults and the vaccines to prevent it. 2023 [cited 2023 May 27]. Available from: https://www.cdc.gov/pneumococcal/resources/prevent-pneumococcal-factsheet.html
Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR MorbMortal Weekl Rep 2019;68(46):1069-75. doi:10.15585/mmwr.mm6846a5.
Petcharavej Hospital. Pneumococcal and influenza vaccines. 2024 [cited June 3, 2024]. Available from: https://www.petcharavejhospital.com/th/Package/package_detail/invasive-pneumococcal-vaccine-2023
Siriraj H Solutions. Vaccination services by age (adults). [cited June 3, 2024]. Available from: https://sirirajhsolutions.com/th/services/vaccination-center-package
Food and Drug Administration. Prevnar 13. 2019. [cited May 30, 2023]. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/prevnar-13
Centers for Disease Control and Prevention. Pneumococcal vaccination. 2024 [cited June 6, 2024]. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/public/index.html
Centers for Disease Control and Prevention. ACIP updates: Recommendations for the use of 20-valent pneumococcal conjugate vaccine in children - United States, 2023. [cited June 6, 2024]. Available from: https://stacks.cdc.gov/view/cdc/133252
Centers for Disease Control and Prevention. Pneumococcal vaccine recommendations. 2024 [cited June 6, 2024]. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html
Centers for Disease Control and Prevention. Pneumococcal vaccination: who and when to vaccinate. 2024 [cited June 6, 2024]. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html
Department of Disease Control, Ministry of Public Health, Thailand. Vaccine and Immunization Textbook 2019. 2019 [cited June 6, 2024]. Available from: https://ddc.moph.go.th/uploads/publish/938420191209023015.pdf
Department of Communicable Diseases, Ministry of Public Health, Thailand. Guidelines for adult immunization programs - revised edition 2022. 2022 [cited June 6, 2024]. Available from: https://ddc.moph.go.th/uploads/publish/1263920220429034131.pdf
Tankeshwar A. T dependent antigen, T independent antigen. 2023 [cited May 31, 2024]. Available from: https://microbeonline.com/t-dependent-antigen-and-t-independent-antigen/
National Vaccine Institute. The action of the vaccine with immunization. 2016 [cited May 31, 2024]. Available from: http://guruvaccine.com
Jochems PS, Weiser NJ, Malley R, Ferreira DM. The immunological mechanisms that control pneumococcal carriage. PLOS Pathogen 2017;13(12):e1006665. doi:10.1371/journal.ppat.1006665.
Martinón-Torres F, Czajka H, Center KJ, Wysocki J, Majda-Stanislawska E, Omeñaca F, et al. 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants. Pediatrics 2015;135(4):e876-86. doi:10.1542/peds.2014-2941.
Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Pediatr Infect Dis J 2012;31(1):72-7. doi:10.1097/INF.0b013e318233049d.
Platt HL, Cardona JF, Haranaka M, Schwartz HI, Perez SN, Dowell A, et al. A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine 2022;40(A):162-172. doi:10.1016/j.vaccine.2021.08.049.
Chu K, Hu Y, Pan H, Wu J, Zhu D, Young MM Jr, et al. A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age. Hum Vaccin Immunother 2023;19(2):2235926. doi:10.1080/21645515.2023.2235926.
Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015;372(12):1114-25. doi:10.1056/nejmoa1408544.
Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2015;62(2):139-47. doi:10.1093/cid/civ803.
Chilson E, Scott DA, Schmoele-Thoma B, Watson W, Moran MM, Isturiz R. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence. Hum Vaccin Immunother 2020;16(11):2758-72. doi:10.1080/21645515.2020.1735224.
Department of Communicable Diseases, Ministry of Public Health, Thailand. Pneumococcal conjugate vaccine in the PCV immunization program - revised edition 2023. 2023 [cited June 6, 2024]. Available from: https://ddc.moph.go.th/uploads/publish/1260620230308032551.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Srinagarind Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
